Item 8.01 Other Events.

On September 13, 2021, AbCellera Biologics Inc., (the "Company"), issued a press release announcing its acquisition of TetraGenetics, Inc. ("TetraGenetics"). The Company acquired TetraGenetics for upfront consideration of $12.5 million in cash with the possibility of future technical milestones payable to TetraGenetics based on successful therapeutic candidates. A copy of the press release is attached herewith as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits



(d) Exhibits


 Exhibit

   No.                                             Description
   99.1            Press Release issued by AbCellera Biologics Inc. on September 13, 2021  .
   104           Cover Page Interactive Data File (embedded within the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses